Pharmacologic basis of the effectiveness of topotecan in the treatment of ovarian carcinoma
Zunino, F.; Perego, P.
Tumori 85(3 Suppl 1: S31-S33
1999
ISSN/ISBN: 0300-8916 PMID: 10542884 Document Number: 511438
Document emailed within 1 workday
Related Documents
Tillement, J.P.; Albengres, E. 2001: The pharmacologic basis of pain treatment Therapie 56(6): 687-696Henningfield, J.E. 1984: Pharmacologic basis and treatment of cigarette smoking Journal of Clinical Psychiatry 45(12 Part 2): 24-34
Strel'tsov, S.A.; Mikheĭkin, A.L.; Nechipurenko, I.D. 2001: Interaction of topotecan--a DNA topoisomerase i inhibitor--with dual-stranded polydeoxyribonucleotides. II. Formation of a complex containing several DNA molecules in the presence of topotecan Molekuliarnaia Biologiia 35(3): 442-450
Sato, A.; Ito, K.; Asano, T.; Sumitomo, M.; Asano, T.; Hayakawa, M. 2007: Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake International Journal of Oncology 30(3): 695-700
Obrecht, J.P. 1973: Pharmacologic basis of leukemia therapy Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 298-310
Mashkovskiĭ, M.D.; Andreeva, N.I. 1975: The pharmacologic basis of the antidepressive activity of the new psychotropic preparation pyrazidol Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 75(3): 430-435
Rao, V.; Bauer, F.; Vredenburgh, J.J. 2016: Refractory Small Cell Carcinoma of the Ovary - Hypercalcemic Type (SCCOHT) Treated with Romidepsin and Topotecan: A Case Report and Review of the Literature Connecticut Medicine 80(9): 529-532
Chang, A.Y. 1997: The potential role of topotecan in the treatment of advanced breast cancer Seminars in Oncology 24(6 Suppl 20: S20
Neijt, J.P. 1999: Cytostatic treatment of ovarian carcinoma Nederlands Tijdschrift Voor Geneeskunde 143(44): 2181-2185
Pfleiderer, A. 1983: Surgical treatment of ovarian carcinoma Münchener Medizinische Wochenschrift 125(44): 986-990
Scarabelli, C.; Campagnutta, E.; Perin, A.; Sopracordevole, F.; Scarpa, A.; Nenzi, F.; Miotto, E. 1985: Splenectomy in the radical surgical treatment of ovarian carcinoma Minerva Ginecologica 37(1-2): 37-41
Scarabelli, C.; Campagnutta, E.; Ciarmiello, G.; Sopracordevole, F.; Nenzi, F.; Perin, A.; Miotto, E. 1986: Cisplatin in high-volume intraperitoneal treatment of ovarian carcinoma Minerva Ginecologica 38(7-8): 609-612
Scarabelli, C.; Campagnutta, E.; Settin, G.C. 1985: Surgical treatment of intestinal occlusions in advanced ovarian carcinoma European Journal of Gynaecological Oncology 6(1): 66-70
Kikuchi, Y.; Kita, T.; Iwano, I.; Miyauchi, M.; Oomori, K.; Kizawa, I.; Kato, K. 1988: Treatment of patients with ovarian carcinoma: experimental and clinical studies Nihon Sanka Fujinka Gakkai Zasshi 40(7): 933-935
Whitacre, C.M.; Zborowska, E.; Gordon, N.H.; Mackay, W.; Berger, N.A. 1997: Topotecan increases topoisomerase IIalpha levels and sensitivity to treatment with etoposide in schedule-dependent process Cancer Research 57(8): 1425-1428
Dursun, P.; Ayhan, A.; Yanik, F.B.; Kuşçu, E. 2009: Ovarian transposition for the preservation of ovarian function in young patients with cervical carcinoma European Journal of Gynaecological Oncology 30(1): 13-15
Willemse, P.H.; Blom van Assendelft, P.H.; Fontein, D.L.; Kloppenburg, M.; Boonstra, H.; de Vries, E.G. 1991: Carboplatin in the treatment of ovarian carcinoma; as effective and less toxic in comparison with cisplatin Nederlands Tijdschrift Voor Geneeskunde 135(35): 1588-1592
Kardinal, C.G.; Luce, J.K. 1977: Evaluation of a hexamethylmelamine and 5-fluorouracil combination in the treatment of advanced ovarian carcinoma Cancer Treatment Reports 61(9): 1691-1693
Bernard, V.; Mornstein, V.; Bourek, A. 2013: Effect of near field ultrasound on carboplatin treatment of ovarian carcinoma cells Indian Journal of Biochemistry and Biophysics 50(4): 284-288
Khan, N.A.; Maajeeni, E.H. 2005: Tubo-ovarian abscess in a postmenopausal woman with underlying ovarian carcinoma Saudi Medical Journal 26(6): 1010-1011